SCHEMBL20660752

SCHEMBL20660752

CNC(=O)Oc1ccc(Br)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
POLB P06746 2/20 0.47
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 5/20 0.44
RAB9A P51151 2/20 0.44
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KMT2A Q03164 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
AAK1 Q2M2I8 2/20 0.43
MEN1 O00255 2/20 0.43
PGR P06401 1/20 0.42
GAA P10253 1/20 0.42
PTGS1 P23219 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ACHE P22303 1/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL499783 0.82 L3MBTL1 (0.48) ALDH1A1LMNASMN1; SMN2KDM4EHPGD
SCHEMBL9416809 0.82 TSHR (0.49) ALDH1A1POLBLMNASMN1; SMN2KDM4E
SCHEMBL28612925 0.81 AAK1 (0.44) ALDH1A1LMNASMN1; SMN2KDM4ERAB9A
SCHEMBL28813220 0.81 KDM4E (0.42) ALDH1A1KDM4EKMT2AL3MBTL1PGR
SCHEMBL2569698 0.81 ALDH1A1 (0.48) ALDH1A1POLBLMNASMN1; SMN2KDM4E
SCHEMBL1737797 0.80 CFD (0.53) ALDH1A1POLBLMNASMN1; SMN2KDM4E
SCHEMBL11643870 0.76 ABCB1 (0.44) ALDH1A1POLBKDM4ERAB9AKMT2A
SCHEMBL5929563 0.76 ACHE (0.50) ALDH1A1POLBLMNASMN1; SMN2KDM4E
SCHEMBL6992953 0.76 KDM4E (0.44) ALDH1A1POLBLMNASMN1; SMN2KDM4E
SCHEMBL28320341 0.75 ALDH1A1 (0.46) ALDH1A1POLBLMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 US disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS AHR, ARNT, RXRB ALDH1A1 879/4885POLB 2222/4885LMNA 1969/4885
US-11548867-B2 Amido compounds as AhR modulators AHR, ARNT, RXRB ALDH1A1 879/4885POLB 2222/4885LMNA 1969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.